Security key
30050B101
Evolent Health, Inc. - Class A Common Stock (EVH)
CUSIP: 30050B101
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Class A Common Stock
- Total 13F shares
- 122,189,782
- Total 13F value
- $3,342,247,641
- Share change
- +4,782,691
- Put/Call ratio
- 327%
- SEC-reported price per share
- $27.23
- Number of holders
- 201
- Value change
- +$125,298,418
- Number of buys
- 98
- Number of sells
- 104
- Shares outstanding
- 113,048,557
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
201
Top holders
10
EVH full security history
Ownership snapshot
Full 13F holder table
Evolent Health, Inc. SEC filings
Evolent Health, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of EVH - Evolent Health, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F
Highest disclosed value: $312,706,666
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $312.71M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$312.71M
BlackRock Finance, Inc.
$230.16M
JPMORGAN CHASE & CO
$177.85M
Rock Springs Capital Management LP
$115.25M
WELLINGTON MANAGEMENT GROUP LLP
$114.82M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$312,706,666
10,320,352 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$230,156,256
7,595,916 shares
|
— | 30 Jun 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
denominator unverified
|
$177,845,638
5,869,493 shares
|
— | 30 Jun 2023 |
| Rock Springs Capital Management LP |
13F
Company
|
—
denominator unverified
|
$115,246,050
3,803,500 shares
|
— | 30 Jun 2023 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
—
denominator unverified
|
$114,822,880
3,789,534 shares
|
— | 30 Jun 2023 |
| Bellevue Group AG |
13F
Company
|
—
denominator unverified
|
$104,484,157
3,448,322 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
201
Shares
122,189,782
Rows available
201
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
216
Q3 2023 holders
201
Holder diff
-15
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|